Diferencia entre revisiones de «Enoxaparin»

(Redirected page to Low Molecular Weight Heparin)
(Switch SMW query from broadtable to table format for better layout with TOC)
 
(No se muestran 17 ediciones intermedias de 5 usuarios)
Línea 1: Línea 1:
#Redirect [[Low Molecular Weight Heparin]]
==General==
*Type: [[Low molecular weight heparin]]
*Dosage Forms: subcutaneous
*Common Trade Names: Lovenox


[[Category:Drugs]]
==Adult Dosing==
===<u>Therapeutic</u> anticoagulation (e.g. treating [[DVT]]/[[PE]], [[unstable angina]])===
*1mg/kg SC q12h
 
{{Chemical prophylaxis of VTE}}
 
==Pediatric Dosing==
''Off-label''
*DVT prophylaxis:
**<2 months: 0.75 mg/kg SC q12hr 
**≥2 months: 0.5 mg/kg SC q12h
*Therapeutic anticoagulation:
**<2 months: 1.5 mg/kg SC q12hr
**≥2 months: 1 mg/kg SC q12hr
 
==Special Populations==
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: B
*Lactation: Unknown risk
*Renal Dosing
**Renal impairment (creatinine clearance <30)
***Use 50% of usual dose or use UFH instead
*Hepatic Dosing: not established
*Obesity
**Weight-based dosing safe up to 190kg (no data available thereafter)
 
==Indications==
*[[DVT]]
*[[PE]]
*[[NSTEMI]]
*[[STEMI]]
 
==Contraindications==
*Allergy to class/drug
 
==Adverse Reactions==
*Bleeding
*Pruritus
*Local skin reaction
 
==Pharmacology==
*Half-life: 4.5h
*Metabolism: hepatic
*Excretion: urine
*Mechanism of Action: inhibits factor Xa by increasing inhibition rate of clotting proteases that are activated by antithrombin III
 
 
==Indications by Condition==
''The following table is automatically generated from disease/condition pages across WikEM.''
 
{{#ask:[[Has DrugName::Enoxaparin]]
|?Has Indication=Indication
|?Has Dose=Dose
|?Has Context=Context
|?Has Route=Route
|?Has Population=Population
|format=table
|headers=plain
|mainlabel=-
|sort=Has Indication
|limit=50
}}
 
==See Also==
*[[Heparin (Unfractionated)]]
*[[Coagulopathy (Main)]]
*[[Anticoagulant reversal for life-threatening bleeds]]
 
==References==
<references/>
 
[[Category:Pharmacology]]
[[Category:Heme/Onc]]
[[Category:Heme/Onc]]

Revisión actual - 21:57 20 mar 2026

General

Adult Dosing

Therapeutic anticoagulation (e.g. treating DVT/PE, unstable angina)

  • 1mg/kg SC q12h

Chemical Prophylaxis of VTE

  • Lovenox 30mg SubQ q12 hrs (if Cr Clearance > 30)
    • Check Anti-Xa level every week EXACTLY 4 hours after 3rd dose of lovenox
      • prophylactic goal: 0.2-0.6
      • therapeutic goal: 0.6-1.2
  • Recheck AntiXa level after each 3rd dose if dose is changed until you are at goal
  • Recheck level every week (usually qMonday) for all patients
  • If renal dysfunction order heparin 5000 Units SubQ q8 hrs (search “SURG DVT/VTE prophylaxis” order set)

Pediatric Dosing

Off-label

  • DVT prophylaxis:
    • <2 months: 0.75 mg/kg SC q12hr
    • ≥2 months: 0.5 mg/kg SC q12h
  • Therapeutic anticoagulation:
    • <2 months: 1.5 mg/kg SC q12hr
    • ≥2 months: 1 mg/kg SC q12hr

Special Populations

  • Pregnancy Rating: B
  • Lactation: Unknown risk
  • Renal Dosing
    • Renal impairment (creatinine clearance <30)
      • Use 50% of usual dose or use UFH instead
  • Hepatic Dosing: not established
  • Obesity
    • Weight-based dosing safe up to 190kg (no data available thereafter)

Indications

Contraindications

  • Allergy to class/drug

Adverse Reactions

  • Bleeding
  • Pruritus
  • Local skin reaction

Pharmacology

  • Half-life: 4.5h
  • Metabolism: hepatic
  • Excretion: urine
  • Mechanism of Action: inhibits factor Xa by increasing inhibition rate of clotting proteases that are activated by antithrombin III


Indications by Condition

The following table is automatically generated from disease/condition pages across WikEM.

IndicationDoseContextRoutePopulation
Non-ST-elevation myocardial infarction1mg/kg BIDAntithrombotic; preferred over UFH unless CABG within 24hrSCAdult
Pulmonary embolism1 mg/kg SC q12hAnticoagulation (1st line, LMWH)SCAdult
ST-segment elevation myocardial infarction30 mg IV bolus, then 1 mg/kg SC q12h (<75yo); 0.75 mg/kg SC q12h (≥75yo); 1 mg/kg SC daily (CrCl <30)Anticoagulation (LMWH)IV/SCAdult
Unstable angina1mg/kg SC q12hrAntithrombotic, alternative to UFHSCAdult

See Also

References